|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0024 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/145 | (2013.01) | ||
| A61K 9/146 | (2013.01) | ||
| A61K 31/122 | (2006.01) | ||
| A61M 31/002 | (2013.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61M 37/0069 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61K 31/4458 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 31/122 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/155 | (2013.01) | ||
| A61K 31/65 | (2006.01) | ||
| A61K 31/198 | (2013.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/404 | (2013.01) | ||
| A61K 31/4458 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61K 31/65 | (2013.01) | ||
| A61M 31/00 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61M 37/00 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 38/26 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3522825 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17859227.5 |
| Date of filing the European patent application | 2017-10-05 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/055432 |
| Date | 2017-10-05 |
| (87) | Number | WO 2018/067882 |
| Date | 2018-04-12 |
| (30) | Number | Date | Country code |
| 201662404643 P | 2016-10-05 | US |
| (72) |
PATEL, Rajesh A. , US
SREEDHARAN, Sunil , US
BHONSLE, Sunil R. , US
|
| (73) |
TITAN PHARMACEUTICALS, INC. ,
400 Oyster Point Blvd., Suite 505, South San Francisco, CA 94080-1958,
US
|
| (54) | IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE |
| IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE |